Predicted to enable ATP binding activity and ATP-dependent DNA damage sensor activity. Predicted to contribute to crossover junction DNA endonuclease activity and four-way junction DNA binding activity. Predicted to be involved in DNA recombination and positive regulation of G2/M transition of mitotic cell cycle. Predicted to act upstream of or within female meiosis sister chromatid cohesion; male meiosis I; and spermatogenesis. Predicted to be located in several cellular components, including mitochondrion; nucleoplasm; and perinuclear region of cytoplasm. Predicted to be part of Rad51B-Rad51C-Rad51D-XRCC2 complex and Rad51C-XRCC3 complex. Predicted to be active in replication fork. Human ortholog(s) of this gene implicated in Fanconi anemia complementation group O and hereditary breast ovarian cancer syndrome. Orthologous to human RAD51C (RAD51 paralog C); PARTICIPATES IN homologous recombination pathway of double-strand break repair; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; bisphenol A; furan.
[Arsenic co-treated with Cadmium co-treated with Lead] results in decreased expression of RAD51C mRNA and [Arsenic co-treated with Cadmium co-treated with Lead] results in decreased expression of RAD51C protein
[Arsenic co-treated with Cadmium co-treated with Lead] results in decreased expression of RAD51C mRNA and [Arsenic co-treated with Cadmium co-treated with Lead] results in decreased expression of RAD51C protein
[Arsenic co-treated with Cadmium co-treated with Lead] results in decreased expression of RAD51C mRNA and [Arsenic co-treated with Cadmium co-treated with Lead] results in decreased expression of RAD51C protein
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RAD51C mRNA
[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RAD51C mRNA
[Arsenic co-treated with Cadmium co-treated with Lead] results in decreased expression of RAD51C mRNA and [Arsenic co-treated with Cadmium co-treated with Lead] results in decreased expression of RAD51C protein
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RAD51C mRNA
[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RAD51C mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RAD51C mRNA
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAD51C mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RAD51C mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RAD51C mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAD51C mRNA